Intellia Therapeutics Inc (NTLA): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 23,111 US Dollar | 9 | 1 | 6 | 2 | 2 |
| #Shares | Short [%] | Short Ratio |
| 140.126.693 | 39,95 | 7,63 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Intellia Therapeutics Inc
Mitarbeiter 377
Handelsplatz NASDAQ
Ticker Symbol NTLA
IPO Datum 2016-05-06
Adresse 400 Technology Square, Cambridge, MA, United States, 02139
Webseite https://www.intelliatx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. John M. Leonard M.D. | President, CEO & Director |
| 2 | Mr. Edward J. Dulac III | Executive VP, CFO & Treasurer |
| 3 | Dr. Birgit Schultes Ph.D. | Executive VP & Chief Scientific Officer |
| 4 | Mr. James E. Basta Esq., J.D. | Executive VP, General Counsel & Corporate Secretary |
| 5 | Dr. Rachel E. Haurwitz Ph.D. | Co-Founder |
| 6 | Dr. Jennifer A. Doudna Ph.D. | Founder & Member of Scientific Advisor Board |
| 7 | Dr. Derrick J. Rossi Ph.D. | Founder & Member of Scientific Advisor Board |
| 8 | Dr. Rodolphe Barrangou M.B.A., Ph.D. | Founder & Member of Scientific Advisor Board |
| 9 | Prof. Luciano Marraffini Ph.D. | Founder & Member of Scientific Advisor Board |
| 10 | Mr. Erik J. Sontheimer Ph.D. | Founder & Member of Scientific Advisor Board |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | ARK Investment Management LLC | 12,04% | 0,23 Mrd. USD |
| 2 | BlackRock Inc | 11,00% | 0,21 Mrd. USD |
| 3 | State Street Corp | 6,59% | 0,12 Mrd. USD |
| 4 | Vanguard Portfolio Management, LLC | 5,23% | 0,10 Mrd. USD |
| 5 | D. E. Shaw & Co LP | 4,60% | 0,09 Mrd. USD |
| 6 | Vanguard Capital Management, LLC | 4,30% | 0,08 Mrd. USD |
| 7 | Two Sigma Investments LLC | 3,74% | 0,07 Mrd. USD |
| 8 | FMR Inc | 3,41% | 0,06 Mrd. USD |
| 9 | RA Capital Management, LLC | 3,23% | 0,06 Mrd. USD |
| 10 | Regeneron Pharmaceuticals Inc | 2,64% | 0,05 Mrd. USD |
| 11 | Geode Capital Management, LLC | 2,59% | 0,05 Mrd. USD |
| 12 | Arrowstreet Capital Limited Partnership | 2,34% | 0,04 Mrd. USD |
| 13 | Amova Asset Management Americas, Inc | 2,07% | 0,04 Mrd. USD |
| 14 | Sumitomo Mitsui Trust Group Inc | 2,07% | 0,04 Mrd. USD |
| 15 | Dimensional Fund Advisors, Inc. | 1,86% | 0,04 Mrd. USD |
| 16 | The Goldman Sachs Group Inc | 1,62% | 0,03 Mrd. USD |
| 17 | UBS Group AG | 1,54% | 0,03 Mrd. USD |
| 18 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,47% | 0,03 Mrd. USD |
| 19 | Contrarius Group Holdings Ltd | 1,40% | 0,03 Mrd. USD |
| 20 | Jupiter Asset Management Limited | 1,32% | 0,03 Mrd. USD |